Press "Enter" to skip to content

New patent for Celator Pharms drug VYXEOS

1
Copyright © DrugPatentWatch. Originally published at New patent for Celator Pharms drug VYXEOS

Annual Drug Patent Expirations for VYXEOS
Annual Drug Patent Expirations for VYXEOS

Vyxeos is a drug marketed by Celator Pharms and is included in one NDA. It is available from one supplier. There are nine patents protecting this drug.

Drug patent litigation for VYXEOS.

This drug has one hundred and sixteen patent family members in twenty-five countries.

The generic ingredient in VYXEOS is cytarabine; daunorubicin. One supplier is listed for this compound. Additional details are available on the cytarabine; daunorubicin profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Celator Pharms drug VYXEOS
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions